SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/16 – ‘EX-23.1’

On:  Wednesday, 3/1/17, at 4:17pm ET   ·   For:  12/31/16   ·   Accession #:  1376339-17-42   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K/A’ on 2/22/17 for 12/31/15   ·   Next:  ‘10-K’ on 3/17/20 for 12/31/18   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/01/17  Mimedx Group, Inc.                10-K       12/31/16   96:9.2M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    885K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     78K 
 3: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     91K 
 4: EX-21.1     Subsidiaries List                                   HTML     25K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     27K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
16: R1          Document and Entity Information                     HTML     53K 
17: R2          Consolidated Balance Sheets                         HTML    115K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
19: R4          Consolidated Statements of Operations               HTML     73K 
20: R5          Consolidated Statements of Stockholders' Equity     HTML    107K 
21: R6          Consolidated Statements of Cash Flows               HTML    113K 
22: R7          Nature of Business                                  HTML     30K 
23: R8          Significant Accounting Policies                     HTML     72K 
24: R9          Liquidity and Capital Resources                     HTML     31K 
25: R10         Acquisition of Stability Inc.                       HTML    164K 
26: R11         Cash Equivalents and Short Term Investments         HTML     28K 
27: R12         Inventories                                         HTML     39K 
28: R13         Property and Equipment                              HTML     44K 
29: R14         Intangible Assets and Royalty Agreement             HTML     70K 
30: R15         Long-Term Debt                                      HTML     32K 
31: R16         Net Income Per Share                                HTML     57K 
32: R17         Equity                                              HTML    144K 
33: R18         Income Taxes                                        HTML     97K 
34: R19         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     46K 
                Investing and Financing Activities                               
35: R20         401k Plan                                           HTML     31K 
36: R21         Related Party Transactions                          HTML     31K 
37: R22         Commitments and Contingencies                       HTML     66K 
38: R23         Quarterly Financial Data (Unaudited)                HTML     78K 
39: R24         Product Revenue Data                                HTML     45K 
40: R25         Subsequent Events                                   HTML     28K 
41: R26         Schedule II - Valuation and Qualifying Accounts     HTML     73K 
42: R27         Significant Accounting Policies (Policies)          HTML    137K 
43: R28         Acquisition of Stability Inc. (Tables)              HTML    154K 
44: R29         Inventories (Tables)                                HTML     40K 
45: R30         Property and Equipment (Tables)                     HTML     41K 
46: R31         Intangible Assets and Royalty Agreement (Tables)    HTML     70K 
47: R32         Net Income Per Share (Tables)                       HTML     68K 
48: R33         Equity (Tables)                                     HTML    142K 
49: R34         Income Taxes (Tables)                               HTML     93K 
50: R35         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     44K 
                Investing and Financing Activities (Tables)                      
51: R36         Commitments and Contingencies (Tables)              HTML     34K 
52: R37         Quarterly Financial Data (Unaudited) (Tables)       HTML     77K 
53: R38         Product Revenue Data (Tables)                       HTML     39K 
54: R39         Nature of Business (Details)                        HTML     27K 
55: R40         Significant Accounting Policies (Details)           HTML     53K 
56: R41         Liquidity and Capital Resources (Details)           HTML     40K 
57: R42         Acquisition of Stability Inc. - Narrative           HTML     74K 
                (Details)                                                        
58: R43         Acquisition of Stability Inc. - Fair Value of       HTML     40K 
                Stock Consideration (Details)                                    
59: R44         Acquisition of Stability Inc. - Preliminarily       HTML    121K 
                Allocation of Purchase Price (Details)                           
60: R45         Acquisition of Stability Inc. - Intangible Assets   HTML     36K 
                Acquired as Part of Acquisition (Details)                        
61: R46         Acquisition of Stability Inc. - Goodwill            HTML     34K 
                Reconciliation (Details)                                         
62: R47         Acquisition of Stability Inc. - Measurement Period  HTML    117K 
                Adjustments (Details)                                            
63: R48         Acquisition of Stability Inc. - Pro Forma           HTML     32K 
                Information (Details)                                            
64: R49         Cash Equivalents and Short Term Investments         HTML     32K 
                (Details)                                                        
65: R50         Inventories (Details)                               HTML     40K 
66: R51         Property and Equipment (Details)                    HTML     54K 
67: R52         Intangible Assets and Royalty Agreement -           HTML     98K 
                Intangible Asssets Activity Summary (Details)                    
68: R53         Intangible Assets and Royalty Agreement -           HTML     29K 
                Narrative (Details)                                              
69: R54         Intangible Assets and Royalty Agreement - Expected  HTML     42K 
                Future Amortization of Intangible Assets (Details)               
70: R55         Long-Term Debt (Details)                            HTML     47K 
71: R56         Net Income Per Share - Computation of Basic and     HTML     50K 
                Dilutive Net Loss per Share (Details)                            
72: R57         Net Income Per Share - Summary of Antidilutive      HTML     38K 
                Securities (Details)                                             
73: R58         Equity - Narrative (Details)                        HTML     82K 
74: R59         Equity - Activity of Stock Options (Details)        HTML     80K 
75: R60         Equity - Exercise Price Ranges (Details)            HTML     77K 
76: R61         Equity - Summary of Unvested Stock Options          HTML     46K 
                (Details)                                                        
77: R62         Equity - Assumptions (Details)                      HTML     45K 
78: R63         Equity - Summary of Restricted Stock Awards         HTML     51K 
                (Details)                                                        
79: R64         Equity - Recognized Stock-Based Compensation        HTML     36K 
                (Details)                                                        
80: R65         Income Taxes - Deferred Tax Assets and Liabilities  HTML     52K 
                (Details)                                                        
81: R66         Income Taxes - Reconciliation of the Federal        HTML     60K 
                Statutory Income Tax (Details)                                   
82: R67         Income Taxes - Schedule of current and deferred     HTML     51K 
                income tax expense (Benefit) (Details)                           
83: R68         Income Taxes - Narrative (Details)                  HTML     51K 
84: R69         Income Taxes - Reconciliation of unrecognized tax   HTML     31K 
                benefits (Details)                                               
85: R70         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     48K 
                Investing and Financing Activities (Details)                     
86: R71         401k Plan (Details)                                 HTML     38K 
87: R72         Related Party Transactions (Details)                HTML     34K 
88: R73         Commitments and Contingencies - Narrative           HTML     56K 
                (Details)                                                        
89: R74         Commitments and Contingencies - Estimated Annual    HTML     38K 
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
90: R75         Quarterly Financial Data (Unaudited) (Details)      HTML     46K 
91: R76         Product Revenue Data (Details)                      HTML     37K 
92: R77         Subsequent Events (Details)                         HTML     33K 
93: R78         Schedule II - Valuation and Qualifying Accounts     HTML     42K 
                (Details)                                                        
95: XML         IDEA XML File -- Filing Summary                      XML    163K 
94: EXCEL       IDEA Workbook of Financial Reports                  XLSX    106K 
10: EX-101.INS  XBRL Instance -- mdxg-20161231                       XML   2.32M 
12: EX-101.CAL  XBRL Calculations -- mdxg-20161231_cal               XML    269K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20161231_def                XML    662K 
14: EX-101.LAB  XBRL Labels -- mdxg-20161231_lab                     XML   1.86M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20161231_pre              XML   1.11M 
11: EX-101.SCH  XBRL Schema -- mdxg-20161231                         XSD    167K 
96: ZIP         XBRL Zipped Folder -- 0001376339-17-000042-xbrl      Zip    257K 


‘EX-23.1’   —   Consent of Experts or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  

Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-153255, 333-183991, 333-189784, 333-199841, and 333-211900 and Form S-3 No. 333-189785) of our reports dated March 1, 2017, included in this Annual Report on Form 10-K of MiMedx Group, Inc. and Subsidiaries (the Company) relating to the consolidated balance sheets of the Company as of December 31, 2016 and 2015, and the related consolidated statements of operations, stockholders’ equity, and cash flows and the related consolidated financial statement schedule for each of the three years in the period ended December 31, 2016, and the effectiveness of internal control over financial reporting for the Company as of December 31, 2016.

/s/ Cherry Bekaert LLP
Atlanta, Georgia
March 1, 2017




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/1/17
For Period end:12/31/165
12/31/1510-K,  10-K/A,  5
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/17/20  Mimedx Group, Inc.                S-8        12/17/20    5:422K                                   Donnelley … Solutions/FA
11/04/20  Mimedx Group, Inc.                10-Q        9/30/20   79:7.4M
11/02/20  Mimedx Group, Inc.                8-A12B                 1:37K
 8/04/20  Mimedx Group, Inc.                10-Q        6/30/20   71:5.9M
 3/20/17  SEC                               UPLOAD9/28/17    1:173K Mimedx Group, Inc.
Top
Filing Submission 0001376339-17-000042   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 4:44:08.1pm ET